Supernus Pharmaceuticals, Inc. (SUPN) Stock Total Returns
Growth of $10,000 chart
2021-04-16 to 2026-04-16 to
$
%
%
Loading chart…
Investment Performance
Final Value
$15,527
Total Return
55.27%
CAGR
9.20%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.29% |
| Median | +1.34% |
| Best | +36.62% |
| Worst | -24.58% |
| % of Windows Positive | 55.6% |
1-Year (252 Trading Days)
| Average | +12.42% |
| Median | +14.44% |
| Best | +75.11% |
| Worst | -35.02% |
| % of Windows Positive | 66.8% |
3-Year (756 Trading Days)
| Average | +20.11% |
| Median | +19.91% |
| Best | +64.92% |
| Worst | -19.87% |
| % of Windows Positive | 86.2% |
Risk Metrics
| Maximum Drawdown | -45.94% |
| Average Drawdown | -16.61% |
| Drawdown Duration | 628 Trading Days |
| Sortino Ratio | 0.61 |
| Calmar Ratio | 0.20 |
| CVaR (5%) | -4.81% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -0.97% (-3.29% ann.) | $96.58 | $0.00 | $0.00 | $0.00 |
| 2025 | +37.44% | +$3744.47 | $0.00 | $0.00 | $0.00 |
| 2024 | +24.95% | +$2494.82 | $0.00 | $0.00 | $0.00 |
| 2023 | -18.87% | $1886.74 | $0.00 | $0.00 | $0.00 |
| 2022 | +22.33% | +$2232.51 | $0.00 | $0.00 | $0.00 |
| 2021 | +15.90% | +$1589.83 | $0.00 | $0.00 | $0.00 |
| 2020 | +6.07% | +$607.08 | $0.00 | $0.00 | $0.00 |
| 2019 | -28.60% | $2859.72 | $0.00 | $0.00 | $0.00 |
| 2018 | -16.64% | $1663.74 | $0.00 | $0.00 | $0.00 |
| 2017 | +57.82% | +$5782.17 | $0.00 | $0.00 | $0.00 |
| 2016 | +87.87% | +$8787.21 | $0.00 | $0.00 | $0.00 |
| 2015 | +61.93% | +$6192.77 | $0.00 | $0.00 | $0.00 |
| 2014 | +10.08% | +$1007.96 | $0.00 | $0.00 | $0.00 |
| 2013 | +5.16% | +$516.04 | $0.00 | $0.00 | $0.00 |
| 2012 partial | +33.52% (+54.15% ann.) | +$3351.96 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy-led rebound / euro-sovereign-crisis overlay partial | May 1, 2012 – July 25, 2012 | +135.94% | +3899.02% | +$13594.04 | $0.00 | $0.00 | $0.00 |
| Secular stagnation / QE / low inflation / duration bull | July 26, 2012 – February 19, 2020 | +88.98% | +8.77% | +$8898.37 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -31.01% | -98.55% | $3100.71 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +38.62% | +69.13% | +$3862.43 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +22.04% | +20.80% | +$2204.41 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +9.04% | +9.63% | +$904.24 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -7.44% | -4.09% | $744.09 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 16, 2026 | +54.59% | +31.88% | +$5458.54 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.